Back to Results
First PageMeta Content
Biology / SLC5A2 / Diabetes mellitus type 1 / Diabetes mellitus / Anti-diabetic medication / Insulin / Sodium-glucose transport proteins / Lexicon Pharmaceuticals / Diabetes / Endocrine system / Medicine


For Immediate Release Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients with Type 2 Diabetes at the American Diabetes Association Meeting TOKYO, JAPAN, June 28, 2010 – A
Add to Reading List

Document Date: 2010-06-27 23:10:21


Open Document

File Size: 39,58 KB

Share Result on Facebook
UPDATE